A two-dimensional screen for AMPK substrates identifies tumor suppressor fumarate hydratase as a preferential AMPKα2

Anna Klaus1, Cécile Polge, Sarah Zorman

  • 1Laboratory of Fundamental and Applied Bioenergetics, University Joseph Fourier, Grenoble Cedex 9, France.

Journal of Proteomics
|April 18, 2012
PubMed

Insights

AMP-activated protein kinase (AMPK) phosphorylates the tumor suppressor fumarate hydratase (FH), enhancing its activity. This discovery offers new insights into cellular energy regulation and potential therapeutic targets for cancer and diabetes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Signaling

Background:

  • AMP-activated protein kinase (AMPK) is a key regulator of energy homeostasis and cellular proliferation.
  • Understanding the complete AMPK signaling network is crucial for developing treatments for metabolic diseases like type II diabetes and cancer.
  • Pharmacological targeting of AMPK holds promise, but requires a deeper knowledge of its substrates and regulatory mechanisms.

Purpose of the Study:

  • To identify novel substrates of AMP-activated protein kinase (AMPK), specifically those phosphorylated by the AMPKα2 isoform.
  • To investigate the functional consequences of AMPK-mediated phosphorylation on identified substrates.
  • To elucidate the role of AMPK-regulated fumarate hydratase (FH) in cellular processes and disease.

Main Methods:

  • A novel two-dimensional in vitro screening approach combining surface plasmon resonance (SPR) for interaction analysis and in vitro phosphorylation assays.
  • Enrichment of proteins interacting with a specific AMPK isoform (AMPKα2β2γ1) to identify preferential substrates.
  • Validation of substrate identification using yeast-two-hybrid assays and in vitro phosphorylation experiments.
  • Assessment of enzyme activity changes upon phosphorylation in vitro and in vivo.

Main Results:

  • The screening identified fumarate hydratase (FH), a known tumor suppressor, as a substrate of the AMPKα2 isoform.
  • FH was confirmed to interact with and be preferentially phosphorylated by AMPKα2.
  • AMPK-mediated phosphorylation significantly increased FH enzyme activity both in vitro and in vivo.
  • Evidence suggests AMPKα2 targets cytosolic and nuclear FH, impacting DNA repair and HIF-1α signaling.

Conclusions:

  • Fumarate hydratase (FH) is a direct substrate of AMP-activated protein kinase (AMPK), specifically the AMPKα2 isoform.
  • Phosphorylation by AMPK enhances FH enzyme activity, suggesting a regulatory role in cellular metabolism and tumor suppression.
  • This finding provides a mechanistic link between energy sensing by AMPK and the tumor suppressor functions of FH, relevant to cancer and metabolic disorders.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...